The Centers for Medicare & Medicaid (CMS) Approved Bracco Diagnostics Inc. Ultrasound Contrast Agent, LumasonÂ® (Sulfur Hexaflouride Lipid-Type a Microspheres) for Injectable Suspension, for Reimbursement, under HOPPS